hrp0092p1-360 | GH and IGFs (2) | ESPE2019
Tamaro Gianluca
, Pizzul Mariagrazia
, Gaeta Giuliana
, Servello Raffaella
, Trevisan Marina
, Ada Materassi Paola Manera
, Macaluso Anna
, Valentini Denis
, Pellegrin Maria Chiara
, Tornese Gianluca
Background: In 2003 recombinant human growth hormone (rhGH) was approved by European Medicines Agency to treat short children born small for gestational age (SGA), but so far no study evaluated the prevalence of SGA children with short stature who qualify for rhGH treatment in Europe.Objectives: To investigate the prevalence of SGA and short stature in children born SGA and of SGA children who qualify for rhGH treatment ...